Atrial fibrillation (AF) and heart failure (HF): To treat the AF, be Sure to treat the HF

Progress in Cardiovascular Nursing

Volumn 23, Issue 3, 2008, Pages 146-149

  Prudente, Liza A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

DRUG COMBINATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; NURSING ASSESSMENT; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; ATRIAL FIBRILLATION; DRUG THERAPY, COMBINATION; HEART FAILURE; HUMANS; INCIDENCE; NURSING ASSESSMENT; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOEMBOLISM; UNITED STATES;

EID: 58149217111     PISSN: 08897204     EISSN: 17517117     Source Type: Journal    
DOI: 10.1111/j.1751-7117.2008.00007.x     Document Type: Article

References (24)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
2. Division for heart disease and stroke prevention. CDC Centers for Disease Control and Prevention. http://www.cdc.gov/dhdsp/library/ fs_heart_failure.htm. Accessed January 7, 2008.
3. Heart disease and stroke statistics:2008 update at-a-glance. American Heart Association.http://www.americanheart.org/downloadable/heart/1200 078608862HS_Stats%202008.final.pdf. Accessed January 7, 2008
4. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med. 1992;327: 685-691.
5. Yusuf S. Effect of enalapril on survival in patients with reduced left-ventricular ejection fractions and congestive- heart-failure. New Eng J Med. 1991;325:293-302.
6. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive-heart-failure - results of a veterans-administrationcooperative study. New Eng J Med. 1986; 314:1547-1552.
7. Massie BM, Fisher SG, Deedwania PC, et al. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. Circulation. 1996;93:2128-2134.
8. Torp-Pedersen C, Moller M, Bloch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish investigations of arrhythmia and mortality on dofetilide study group. N Engl J Med. 1999;341:857-865.
9. Doval HC, Nul DR, Grancelli HO, et al. Randomized trial of low-dose amiodarone in severe congestive-heart-failure. Lancet. 1994;344:493-498.
10. Swedberg K. Effects of enalapril on mortality in severe congestive-heart-failure - results of the cooperative-North-Scandinavian-enalapril-survivalstudy (consensus). New Eng J Med. 1987;316: 1429-1435.
11. Markides V, Prystowsky EN. Mechanisms underlying the development of atrial arrhythmias in heart failure. Curr Opin Cardiol. 2003;18:32-38.
12. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality - The Framingham Heart Study. Circulation. 2003;107: 2920-2925.
13. Miyasaka Y, Barnes ME, Gersh BJ, et al. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: A community-based study over two decades. Eur Heart J. 2006;27: 936-941.
14. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation. 2001;104:2118-2150.
15. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation. JAMA. 2001;285: 2864-2870.
16. Vermes E, Tardif JC, Bourassa MG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction - insight from the studies of left ventricular dysfunction (SOLVD) trials. Circulation. 2003;107:2926-2931.
17. Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol - the losartan intervention for end point reduction in hypertension (LIFE) study. J Am Coll Cardiol. 2005;45:712-719.
18. Maggioni AP, Latini R, Carson PE, et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J. 2005;149:548-557.
19. The effect of digoxin on mortality and morbidity in patients with heart failure. The digitalis investigation group. N Engl J Med. 1997;336:525-533.
20. Olshansky B, Rosenfeld LE, Warner AL, et al. The atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study: Approaches to control rate in atrial fibrillation. J Am Coll Cardiol. 2004;43:1201-1208.
21. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. New Eng J Med. 2008;358:2667-2677.
22. Madrid AH, Bueno MG, Rebollo JMG, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study. Circulation. 2002;106:331-336.
23. Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol. 2005;16:1160-1165.
24. Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. New Eng J Med. 2004;351:2373-2383.